MBRX - Moleculin Biotech, Inc.

QQQ $ 609.08 $ -12.68 (-2.04 %)

DIA $ 475.22 $ -8.02 (-1.66 %)

SPY $ 672.80 $ -11.34 (-1.66 %)

TLT $ 89.38 $ -0.74 (-0.82 %)

GLD $ 384.25 $ -3.12 (-0.81 %)

Previous Close

$ 0.4539

Open

$ 0.47

Bid

$ 0.44 x 100

Ask

$ 0.45 x 100

Day's Range

$ 0.43 - $ 0.49

52 Week Range

$ 0.25 - $ 3.65

Volume

2,586,607

Average Volume

Market Cap

23.11M

Beta (5Y Monthly)

$ 1.71

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-13-2025	09-30-2025	10-Q
2	08-12-2025	06-30-2025	10-Q
3	05-13-2025	03-31-2025	10-Q
4	03-21-2025	12-31-2024	10-K
5	11-08-2024	09-30-2024	10-Q
6	08-13-2024	06-30-2024	10-Q
7	05-10-2024	03-31-2024	10-Q
8	03-22-2024	12-31-2023	10-K
9	11-13-2023	09-30-2023	10-Q
10	08-10-2023	06-30-2023	10-Q
11	05-10-2023	03-31-2023	10-Q
12	03-22-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-12-2022	06-30-2022	10-Q
15	05-11-2022	03-31-2022	10-Q
16	03-24-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-11-2021	06-30-2021	10-Q
19	05-12-2021	03-31-2021	10-Q
20	03-24-2021	12-31-2020	10-K
21	11-12-2020	09-30-2020	10-Q
22	08-12-2020	06-30-2020	10-Q
23	05-11-2020	03-31-2020	10-Q
24	03-19-2020	12-31-2019	10-K
25	11-12-2019	09-30-2019	10-Q
26	08-16-2019	06-30-2019	10-Q
27	05-13-2019	03-31-2019	10-Q
28	02-21-2019	12-31-2018	10-K
29	11-13-2018	09-30-2018	10-Q
30	08-10-2018	06-30-2018	10-Q
31	05-14-2018	03-31-2018	10-Q
32	03-28-2018	12-31-2017	10-K
33	11-13-2017	09-30-2017	10-Q
34	08-11-2017	06-30-2017	10-Q
35	05-12-2017	03-31-2017	10-Q
36	04-03-2017	12-31-2016	10-K
37	11-21-2016	09-30-2016	10-Q
38	08-15-2016	06-30-2016	10-Q
39	06-16-2016	03-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Moleculin Reports 60% of First 45 Subjects...
11/13/2025 13:39:21

Moleculin Announced Grant Funded Research ...
11/12/2025 13:39:37

Preclinical research to be conducted at the University of North Carolina at Chapel Hill (UNC) Annamycin will be used in conjunc...

Moleculin Biotech To Present Updates On It...
10/30/2025 12:42:11

Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with...

Moleculin Secures Australian Patent For Pr...
10/29/2025 12:38:36

Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with...

Moleculin Biotech Enters Collaboration Wit...
10/23/2025 12:05:14

Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with...

12 Health Care Stocks Moving In Wednesday'...
10/22/2025 21:06:21

Moleculin Biotech Secures Canadian Patent ...
09/25/2025 12:40:12

Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company wit...

Moleculin Biotech Files Prospectus For Res...
09/19/2025 21:21:15

-SEC Filing

12 Health Care Stocks Moving In Thursday's...
09/18/2025 21:06:10

HC Wainwright & Co. Reiterates Buy on Mole...
09/10/2025 10:52:14

HC Wainwright & Co. analyst Sara Nik reiterates Moleculin Biotech (NASDAQ:MBRX) with a Buy and maintains $4 price target.

$moleculin-biotech-announces-its-phase-2b3-miracle-trial-for-annarac-in-relapsed-or-refractory-acute-myeloid-leukemia-is-progressing-with-active-sites-and-ongoing-patient-recruitment-across-the-us-europe-and-the-middle-east$

Moleculin Biotech Announces Its Phase 2B/3...
09/09/2025 12:48:45

Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company wit...

Moleculin Biotech Opens Spain Site, Enroll...
09/08/2025 12:41:48

Spain site opens with two R/R AML subjects enrolled; One treatedOn track to recruit 45 subjects in 4Q25 for initial data unblin...

12 Health Care Stocks Moving In Thursday's...
08/28/2025 17:06:35

nasdaq-surges-100-points-dollar-general-earnings-beat-views

Nasdaq Surges 100 Points; Dollar General E...
08/28/2025 16:54:43

Reported Earlier: Moleculin Biotech Raises...
08/28/2025 16:51:01

Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with...

US Stocks Mixed; Nvidia Posts Upbeat Earnings
08/28/2025 14:27:31

HC Wainwright & Co. Reiterates Buy on Mole...
08/27/2025 15:43:38

HC Wainwright & Co. analyst Sara Nik reiterates Moleculin Biotech (NASDAQ:MBRX) with a Buy and maintains $4 price target.

Moleculin Biotech Completes Phase 1B/2 Cli...
08/27/2025 12:48:14

Median Overall Survival (OS) of 15 months for subjects with complete remission (n=8)Median OS of 2nd Line efficacy evaluable po...

Moleculin Biotech Q2 EPS $(0.49) Misses $(...
08/12/2025 21:57:24

Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $...

Moleculin Highlights Preclinical Data For ...
08/06/2025 12:45:15

Presented data highlights the potential of Annamycin for treating broad range of human cancers, including high-need oncology in...